Clinical Trials in Houston

Showing 4261-4280 of 17,885 trials

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

NCT05673083

The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with multiple myeloma. The main question it aims to answer are: • Does All4Cure effect patient activation as assessed by the PAM-13 survey? Participants will be asked to: * fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation. * fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website. * fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.

Multiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory+1 more

All4Cure200 participantsStarted Mar 2023

Fayetteville, Arkansas, United States • Jacksonville, Florida, United States • Des Moines, Iowa, United States +4 more locations

COMPLETEDNA< 1 mile

Prospective Evaluation of Self-Testing to Increase Screening

NCT03898167

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.

Cervical CancerHuman Papillomavirus Infection

Baylor College of Medicine2,474 participantsStarted Feb 2020

Houston, Texas, United States

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Prospective Evaluation of Self-Testing to Increase Screening

Find Trials by Condition in Houston

Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

A Study of Abemaciclib in Recurrent Glioblastoma

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

MR Image Synthesis With Low Gadobutrol Dose and AI

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEF

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis

The Care Ecosystem Consortium Effectiveness Study

Open-Label Extension Study of Setmelanotide

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations